NATH BIOGENES (INDIA)
Back to Income Statement
|
NATH BIOGENES (INDIA) Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹39 Cr | ₹40 Cr | ₹35 Cr | ₹-67 Cr | ₹12 Cr |
What is the latest Consolidated Net Profit of NATH BIOGENES (INDIA) ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹39 Cr |
| Mar2024 | ₹40 Cr |
| Mar2023 | ₹35 Cr |
| Mar2022 | ₹-67 Cr |
| Mar2013 | ₹12 Cr |
How is Consolidated Net Profit of NATH BIOGENES (INDIA) Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹39 Cr | -2.57 | |
| Mar2024 | ₹40 Cr | 13.11 | |
| Mar2023 | ₹35 Cr | Positive | |
| Mar2022 | ₹-67 Cr | Negative | |
| Mar2013 | ₹12 Cr | - | |
Compare Consolidated Net Profit of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹306.5 Cr | -3.3% | -5.8% | -8.9% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,384.3 Cr | 4.8% | -6.3% | -22.9% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,244.7 Cr | -4.7% | -3.9% | 17.1% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,900.9 Cr | -0.6% | -6.7% | -20.9% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,190.5 Cr | -3.2% | -7.8% | -24.2% | Stock Analytics | |
| INDO US BIOTECH | ₹243.6 Cr | -5.7% | NA | -48.6% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -3.3% |
-5.8% |
-8.9% |
| SENSEX | 1.4% |
2% |
10.2% |
You may also like the below Video Courses